Scientists Find Cancer's Hidden Weakness in Common Molecule

Scientists at the University of Rochester just uncovered a surprising weakness in cancer cells that could change how we fight the disease.

Tumors are using glutathione, a molecule our bodies naturally produce to protect cells from damage, as their own personal fuel source. The discovery challenges everything researchers thought they knew about how antioxidants work in cancer.

Dr. Isaac Harris and his team at the Wilmot Cancer Institute published their findings in Nature this month. They found that cancer cells break down glutathione differently than healthy cells do, essentially turning a protective molecule into energy to keep growing.

"Cancer cells and normal cells potentially use different food sources," Harris explained. His team discovered exactly how cancer cells hijack this antioxidant and convert it into fuel, something scientists never thought was possible.

The researchers examined fluid from breast tumor samples and found high levels of glutathione inside. When they blocked the tumor's ability to use glutathione in lab models, tumor growth slowed down significantly.

This isn't limited to just one cancer type either. Early data suggests many different tumors consume glutathione, making this discovery potentially relevant for multiple cancer treatments.

The Bright Side

This finding opens an entirely new approach to cancer treatment. The team has already identified a promising drug candidate that could block tumors from using glutathione, and chemists are now working to refine it.

The long-term goal is creating treatments that destroy cancer cells while leaving healthy cells completely unharmed. Since cancer cells rely on glutathione as fuel differently than normal cells do, doctors might finally have a way to target tumors precisely.

Harris's colleague, Dr. Jeevisha Bajaj, made a similar discovery last year showing that taurine (another antioxidant in energy drinks) can promote leukemia cell growth. These findings together suggest scientists need to rethink how cancer cells feed themselves.

The team wants to be clear about what this means for everyday people. Eating fruits and vegetables rich in antioxidants is still important for overall health, weight control, and immune function.

However, Harris cautions against taking high-dose glutathione supplements, which are unregulated by the FDA. "Taking a pill that has a high concentration of glutathione can present risks," he warned.

Future research will test combinations of anticancer drugs alongside dietary strategies to find the best outcomes. The team is also working to identify the specific proteins that allow tumors to process glutathione.

"Even though glutathione was discovered 100 years ago, we are finding completely new aspects to its biology," Harris said, expressing hope that these discoveries will translate into new therapies that finally give patients better options.